Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study

Fig. 1

Cumulative survival curves after treatment with concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy. a Overall survival; b Progression-free survival; c Distant metastasis-free survival; d Locoregional failure -free survival. HR, hazard ratio; CI, confidence interval

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us